A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive
Clinical trial NCT00002215 · COMPLETED
Trial details
- NCT number
- NCT00002215
- Sponsor
- Triangle Pharmaceuticals
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.